GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

According to a new market research report titled, 'Dietary Supplements Market Size, Share, Forecast, & Trends Analysis by ...

According to a new market research report titled, 'Dietary Supplements Market Size, Share, Forecast, & Trends Analysis by ...

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth as well. Sadly, it hasn't turned out that way. The post Down 25% with a 4.32% ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

In the sporting world, Olympian Tom Daley, openly gay football player Jack Daniels and boxer Cindy Ngamba are in the running ...

India’s Ministry of Health has taken no steps to stop other pharmaceutical companies from continuing to manufacture and sell ...

Advisory for Biometric-Based Aadhaar Authentication and Document Verification for GST Registration Applicants of Madhya ...

Europe’s largest companies are increasingly responding to investor, regulatory and public demand for transparency in AI ...

Abbott India launched PneumoShield 14, a pneumonia vaccine for children aged six weeks and older. This vaccine offers broader ...

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation.